Drug
Solithromycin clinical trials
Also written CEM-101.
- studies test it
- 11
- open now
- 0
- in phase 3
- 4
- first study started
- 2010
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
11 studies that test it; most in 2015 (4)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 5
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 2
Melinta Therapeutics, Inc. (9) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Imperial College London (1)
Studies
Open first, then newest update. How each study uses solithromycin is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary DiseaseTerminatedPhase 2Imperial College LondonNCT02628769Written as Solithromycin
- Genitourinary and Pharyngeal Pharmacokinetics of SolithromycinCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02348424Written as Solithromycin
- Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial PneumoniaTerminatedPhase 2/3Melinta Therapeutics, Inc.NCT02605122Written as Solithromycin
- Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With GonorrheaCompletedPhase 3Melinta Therapeutics, Inc.NCT02210325Written as solithromycin
- Pharmacokinetics and Safety of Solithromycin in Adolescents and ChildrenCompletedPhase 1Melinta Therapeutics, Inc.NCT02268279Written as solithromycin
- Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without CirrhosisCompletedPhase 2Melinta Therapeutics, Inc.NCT02510599Written as solithromycin
- Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial PneumoniaCompletedPhase 3Melinta Therapeutics, Inc.NCT01756339Written as Solithromycin
- Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial PneumoniaCompletedPhase 2Melinta Therapeutics, Inc.NCT01168713Written as CEM-101
- Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital GonorrheaCompletedPhase 2Melinta Therapeutics, Inc.NCT01591447Written as solithromycin
- Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial PneumoniaCompletedPhase 3Melinta Therapeutics, Inc.NCT01968733Written as Solithromycin
- Pharmacokinetics and Safety of Solithromycin Capsules in AdolescentsCompletedPhase 1Melinta Therapeutics, Inc.NCT01966055Written as Solithromycin
Codes
What other systems call solithromycin · ClinicalTrials.gg INT005586
- MeSH (NLM) C547755solithromycinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 9U1ETH79CKSOLITHROMYCINConfirmed FDA, NLM, Wikidata
- Wikidata Q7558263SolithromycinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152386SolithromycinOne source FDA
- DrugBank DB09308One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C547755 | solithromycin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 9U1ETH79CK | SOLITHROMYCIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7558263 | Solithromycin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152386 | Solithromycin | One source FDA |
| DrugBank | DB09308 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.